Cost effectiveness analysis of pharmacokinetically-guided 5-fluorouracil in FOLFOX chemotherapy for metastatic colorectal cancer.
第一作者:
Daniel A,Goldstein
第一单位:
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA. Electronic address: dgolds8@emory.edu.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);结直肠肿瘤(Colorectal Neoplasms);费用效益分析(Cost-Benefit Analysis);药物监测(Drug Monitoring);女(雌)性(Female);氟尿嘧啶(Fluorouracil);随访研究(Follow-Up Studies);人类(Humans);醛氢叶酸(Leucovorin);男(雄)性(Male);Markov链(Markov Chains);中年人(Middle Aged);模型, 经济计量学(Models, Econometric);肿瘤分期(Neoplasm Staging);有机铂化合物(Organoplatinum Compounds);预后(Prognosis);生活质量(Quality of Life);质量校正寿命(Quality-Adjusted Life Years);存活率(Survival Rate);组织分布(Tissue Distribution)
DOI
10.1016/j.clcc.2014.09.007
PMID
25306485
发布时间
2018-12-02
- 浏览51

Clinical colorectal cancer
219-25页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文